JPS5522636A
(en)
*
|
1978-08-04 |
1980-02-18 |
Takeda Chem Ind Ltd |
Thiazoliding derivative
|
JPS5697277A
(en)
*
|
1980-01-07 |
1981-08-05 |
Takeda Chem Ind Ltd |
Thiazolidine derivative
|
AU6610081A
(en)
*
|
1980-01-24 |
1981-07-30 |
Senju Pharmaceutical Co., Ltd. |
Thiazolidine derivatives
|
JPS58118577A
(ja)
*
|
1982-01-07 |
1983-07-14 |
Takeda Chem Ind Ltd |
チアゾリジン誘導体
|
JPS6051189A
(ja)
*
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
WO1985004170A1
(en)
*
|
1984-03-21 |
1985-09-26 |
Takeda Chemical Industries, Ltd. |
Thiazolidinedione derivatives, process for their preparation, and medicinal composition containing same
|
US4582839A
(en)
*
|
1984-03-21 |
1986-04-15 |
Takeda Chemical Industries, Ltd. |
2,4-thiazolidinediones
|
JPS6143114A
(ja)
*
|
1984-08-03 |
1986-03-01 |
Takeda Chem Ind Ltd |
虹彩・毛様体疾患治療用眼局所投与剤
|
WO1986002073A1
(en)
*
|
1984-10-03 |
1986-04-10 |
Takeda Chemical Industries, Ltd. |
Thiazolidinedione derivatives, process for their preparation, and pharmaceutical composition containing same
|
CN1003445B
(zh)
*
|
1984-10-03 |
1989-03-01 |
武田药品工业株式会社 |
噻唑烷二酮衍生物,其制备方法和用途
|
AR240698A1
(es)
*
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
DK173350B1
(da)
|
1985-02-26 |
2000-08-07 |
Sankyo Co |
Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
|
US4738972A
(en)
*
|
1985-05-21 |
1988-04-19 |
Pfizer Inc. |
Hypoglycemic thiazolidinediones
|
HU210339B
(en)
*
|
1985-05-21 |
1995-03-28 |
Pfizer |
Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
|
JPH06779B2
(ja)
*
|
1985-06-10 |
1994-01-05 |
武田薬品工業株式会社 |
チアゾリジオン誘導体およびそれを含んでなる医薬組成物
|
US5356917A
(en)
*
|
1985-08-09 |
1994-10-18 |
Eli Lilly And Company |
Aryl-substituted rhodanine derivatives
|
US5691367A
(en)
*
|
1985-08-09 |
1997-11-25 |
Eli Lilly And Company |
Aryl-substituted rhodanine derivatives
|
GB8528633D0
(en)
*
|
1985-11-21 |
1985-12-24 |
Beecham Group Plc |
Compounds
|
US4873255A
(en)
*
|
1987-02-04 |
1989-10-10 |
Sankyo Company Limited |
Thiazolidinone derivatives, their preparation and their use
|
JPS63230689A
(ja)
*
|
1987-03-18 |
1988-09-27 |
Tanabe Seiyaku Co Ltd |
ベンゾオキサジン誘導体
|
WO1988009661A1
(en)
*
|
1987-06-10 |
1988-12-15 |
Pfizer Inc. |
Oxazolidin-2-one derivatives as hypoglycemic agents
|
EP0295828A1
(de)
*
|
1987-06-13 |
1988-12-21 |
Beecham Group Plc |
Chemische Verbindungen
|
EP0306228B1
(de)
*
|
1987-09-04 |
1999-11-17 |
Beecham Group Plc |
Substituierte Thiazolidindionderivate
|
US5521201A
(en)
*
|
1987-09-04 |
1996-05-28 |
Beecham Group P.L.C. |
Method for treatment of atherosclerosis
|
US4798835A
(en)
*
|
1987-12-02 |
1989-01-17 |
Pfizer Inc. |
dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
|
US4791125A
(en)
*
|
1987-12-02 |
1988-12-13 |
Pfizer Inc. |
Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
|
US5330998A
(en)
*
|
1988-03-08 |
1994-07-19 |
Pfizer Inc. |
Thiazolidinedione derivatives as hypoglycemic agents
|
US5223522A
(en)
*
|
1988-03-08 |
1993-06-29 |
Pfizer Inc. |
Thiazolidinedione hypoglycemic agents
|
WO1989008650A1
(en)
*
|
1988-03-08 |
1989-09-21 |
Pfizer Inc. |
Thiazolidinedione hypoglycemic agents
|
US5120754A
(en)
*
|
1988-03-08 |
1992-06-09 |
Pfizer Inc. |
Thiazolidinedione hypoglycemic agents
|
MX15171A
(es)
*
|
1988-03-08 |
1993-05-01 |
Pfizer |
Derivados de tiazolidinodiona hipoglicemicos
|
US5130379A
(en)
*
|
1988-03-08 |
1992-07-14 |
Pfizer Inc. |
Hypoglycemic thiazolidinedione derivatives
|
GB8820389D0
(en)
*
|
1988-08-26 |
1988-09-28 |
Beecham Group Plc |
Novel compounds
|
GB8919417D0
(en)
|
1989-08-25 |
1989-10-11 |
Beecham Group Plc |
Novel compounds
|
US5053420A
(en)
*
|
1989-10-13 |
1991-10-01 |
Pershadsingh Harrihar A |
Thiazolidine derivatives for the treatment of hypertension
|
WO1991007107A1
(en)
*
|
1989-11-13 |
1991-05-30 |
Pfizer Inc. |
Oxazolidinedione hypoglycemic agents
|
US5036079A
(en)
*
|
1989-12-07 |
1991-07-30 |
Pfizer Inc. |
Hypoglycemic thiazolidinedione derivatives
|
US5216002A
(en)
*
|
1989-12-21 |
1993-06-01 |
Eli Lilly And Company |
Method of treating inflammatory bowel disease
|
US5143930A
(en)
*
|
1990-02-07 |
1992-09-01 |
Sankyo Company, Limited |
Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
|
US5356913A
(en)
*
|
1990-02-09 |
1994-10-18 |
The Upjohn Company |
Use of insulin sensitizing agents to treat hypertension
|
CA2071629C
(en)
†
|
1990-02-09 |
1997-12-30 |
Jerry R. Colca |
Use of insulin sensitizing agents to treat hypertension
|
ATE205206T1
(de)
*
|
1990-04-27 |
2001-09-15 |
Sankyo Co |
Benzylidenthiazolidinderivate, ihre herstellung und ihre anwendung als lipidperoxid-inhibitoren
|
US5037842A
(en)
*
|
1990-06-05 |
1991-08-06 |
Pfizer Inc. |
Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
|
US5089514A
(en)
*
|
1990-06-14 |
1992-02-18 |
Pfizer Inc. |
3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
|
US5334604A
(en)
*
|
1990-08-23 |
1994-08-02 |
Pfizer Inc. |
Hypoglycemic hydroxyurea derivatives
|
JPH0445604U
(de)
*
|
1990-08-24 |
1992-04-17 |
|
|
GB9023585D0
(en)
*
|
1990-10-30 |
1990-12-12 |
Beecham Group Plc |
Novel compounds
|
GB9023584D0
(en)
*
|
1990-10-30 |
1990-12-12 |
Beecham Group Plc |
Novel compounds
|
JPH04210683A
(ja)
*
|
1990-12-06 |
1992-07-31 |
Terumo Corp |
チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
|
US5158966A
(en)
*
|
1991-02-22 |
1992-10-27 |
The University Of Colorado Foundation, Inc. |
Method of treating type i diabetes
|
JP3053490B2
(ja)
*
|
1991-02-25 |
2000-06-19 |
杏林製薬株式会社 |
チアゾリジン−2,4−ジオン誘導体とその塩及び製造法
|
US5183823A
(en)
*
|
1991-04-11 |
1993-02-02 |
Takeda Chemical Industries, Ltd. |
Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
|
DE69231886T2
(de)
*
|
1991-04-11 |
2002-03-28 |
Pharmacia & Upjohn Co., Kalamazoo |
Thiazolidindionderivate, herstellung und anwendung
|
US5441971A
(en)
*
|
1991-04-11 |
1995-08-15 |
The Upjohn Company |
Thiazolidinedione derivatives, production and use thereof
|
TW222626B
(de)
|
1991-07-22 |
1994-04-21 |
Pfizer |
|
FR2680512B1
(fr)
*
|
1991-08-20 |
1995-01-20 |
Adir |
Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
GB9124513D0
(en)
*
|
1991-11-19 |
1992-01-08 |
Smithkline Beecham Plc |
Novel process
|
NO302519B1
(no)
*
|
1991-12-26 |
1998-03-16 |
Sankyo Co |
Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
|
NO302471B1
(no)
*
|
1991-12-26 |
1998-03-09 |
Sankyo Co |
Tiazolidinforbindelser og farmasöytisk preparat
|
US5498621A
(en)
*
|
1992-05-01 |
1996-03-12 |
Pfizer Inc. |
Oxazolidinedione hypoglycemic agents
|
ZA936324B
(en)
|
1992-08-31 |
1994-03-22 |
Sankyo Co |
Oxazolidine derivatives having anti-diabetic and anti-obesity properties their preparation and their therapeutic uses
|
NZ248573A
(en)
*
|
1992-09-10 |
1996-02-27 |
Lilly Co Eli |
5-arylmethyl (and methylidene) thiazolidin-4-one derivatives; their preparation and pharmaceutical compositions
|
FR2696743B1
(fr)
*
|
1992-10-12 |
1994-12-23 |
Adir |
Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.
|
US5591862A
(en)
*
|
1993-06-11 |
1997-01-07 |
Takeda Chemical Industries, Ltd. |
Tetrazole derivatives, their production and use
|
USRE39384E1
(en)
|
1993-09-01 |
2006-11-07 |
Smithkline Beecham P.L.C. |
Substituted thiazolidinedione derivatives
|
US6046222A
(en)
*
|
1993-09-15 |
2000-04-04 |
Warner-Lambert Company |
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
|
US5874454A
(en)
*
|
1993-09-15 |
1999-02-23 |
Warner-Lambert Company |
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
|
AU749416B2
(en)
*
|
1993-09-15 |
2002-06-27 |
Daiichi Sankyo Company, Limited |
Use of thiazolidinediones to prevent or delay onset of NIDDM
|
EP0719140B1
(de)
*
|
1993-09-15 |
2007-10-31 |
Daiichi Sankyo Company, Limited |
Verwendung von thiazolidindionen zur vorbeugung oder verzögerung des auftretens des nichtinsulinabhängigen diabetes mellitus (niddm)
|
US5457109A
(en)
*
|
1993-09-15 |
1995-10-10 |
Warner-Lambert Company |
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
|
US5401761A
(en)
*
|
1993-12-09 |
1995-03-28 |
Pfizer, Inc. |
Thiazolidinedione hypoglycemic agents
|
US6251928B1
(en)
*
|
1994-03-16 |
2001-06-26 |
Eli Lilly And Company |
Treatment of alzheimer's disease employing inhibitors of cathepsin D
|
CA2145257A1
(en)
*
|
1994-03-23 |
1995-09-24 |
Takashi Fujita |
Thiazolidine and oxazolidine derivatives, their preparation and their medical use
|
IL113313A
(en)
*
|
1994-04-11 |
1999-09-22 |
Sankyo Co |
Heterocyclic compounds and pharmaceutical compositions containing the same
|
US5594015A
(en)
*
|
1994-06-22 |
1997-01-14 |
Regents Of The University Of California |
Thiazolidine derivatives for the treatment of psoriasis
|
CA2159938A1
(en)
*
|
1994-10-07 |
1996-04-08 |
Hiroaki Yanagisawa |
Oxime derivatives, their preparation and their therapeutic use
|
US5925656A
(en)
*
|
1995-04-10 |
1999-07-20 |
Dr. Reddy's Research Foundation |
Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
US5708012A
(en)
*
|
1995-04-28 |
1998-01-13 |
Sankyo Company, Limited |
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
|
CZ293016B6
(cs)
*
|
1995-06-01 |
2004-01-14 |
Sankyo Company Limited |
Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
|
JPH09136877A
(ja)
*
|
1995-06-16 |
1997-05-27 |
Takeda Chem Ind Ltd |
複素環化合物、その製造法及び用途
|
TWI238064B
(en)
*
|
1995-06-20 |
2005-08-21 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
NO318765B1
(no)
*
|
1995-07-03 |
2005-05-02 |
Sankyo Co |
Anvendelse av en HMG-CoA reduktaseinhibitor og en insulinsensibilisator til fremstilling av et medikament for forebyggelse eller behandling av arteriosklerose eller xantom, samt pakket farmasoytisk preparat som omfatter de to midlene i separate porsjoner.
|
WO1997018811A1
(en)
*
|
1995-11-17 |
1997-05-29 |
Warner-Lambert Company |
A method of treating myotonic dystrophy
|
GB9604242D0
(en)
|
1996-02-28 |
1996-05-01 |
Glaxo Wellcome Inc |
Chemical compounds
|
IL120443A
(en)
*
|
1996-03-18 |
2000-07-16 |
Sankyo Co |
Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
|
DK0916651T3
(da)
*
|
1996-04-04 |
2003-12-01 |
Sankyo Co |
Phenylalkylcarboxylsyrederivater
|
JPH09323930A
(ja)
*
|
1996-04-04 |
1997-12-16 |
Takeda Chem Ind Ltd |
悪液質の予防・治療剤
|
US5889025A
(en)
*
|
1996-05-06 |
1999-03-30 |
Reddy's Research Foundation |
Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
US5919782A
(en)
*
|
1996-05-06 |
1999-07-06 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
US5889032A
(en)
*
|
1996-05-06 |
1999-03-30 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
US5801173A
(en)
*
|
1996-05-06 |
1998-09-01 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
CA2257284C
(en)
*
|
1996-05-31 |
2005-10-04 |
Sankyo Company Limited |
Remedy for autoimmune diseases
|
FR2749583B1
(fr)
*
|
1996-06-07 |
1998-08-21 |
Lipha |
Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
|
US6372750B2
(en)
|
1996-07-01 |
2002-04-16 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
|
US6114526A
(en)
|
1996-07-01 |
2000-09-05 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
USRE39266E1
(en)
|
1996-07-01 |
2006-09-05 |
Dr. Reddy's Laboratories, Limited |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
US5885997A
(en)
*
|
1996-07-01 |
1999-03-23 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
CZ298812B6
(cs)
*
|
1996-07-01 |
2008-02-13 |
Dr. Reddy's Laboratories Limited |
Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí
|
AU2995497A
(en)
*
|
1996-07-26 |
1997-11-19 |
Dr. Reddy's Research Foundation |
Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
|
US5814647A
(en)
|
1997-03-04 |
1998-09-29 |
Board Of Regents, The University Of Texas System |
Use of troglitazone and related compounds for the treatment of the climacteric symptoms
|
EP1006794B1
(de)
*
|
1997-03-12 |
2007-11-28 |
Robert W. Esmond |
Verfahren zur behandlung oder prävention der alzheimerischen krankheit
|
DE19711617A1
(de)
*
|
1997-03-20 |
1998-09-24 |
Boehringer Mannheim Gmbh |
Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
SE9702305D0
(sv)
|
1997-06-17 |
1997-06-17 |
Astra Ab |
New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
|
ATE355840T1
(de)
*
|
1997-06-18 |
2007-03-15 |
Smithkline Beecham Plc |
Behandlung der diabetes mit thiazolidindione und metformin
|
CN1168451C
(zh)
*
|
1997-06-18 |
2004-09-29 |
史密丝克莱恩比彻姆有限公司 |
噻唑烷二酮和磺酰脲组合物在制备治疗糖尿病的药物中的用途
|
GB9715295D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
GB9715306D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
IL135177A0
(en)
|
1997-10-02 |
2001-05-20 |
Sankyo Co |
Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
|
GB9723295D0
(en)
|
1997-11-04 |
1998-01-07 |
Smithkline Beecham Plc |
Novel process
|
US7091359B2
(en)
|
1997-11-04 |
2006-08-15 |
Smithkline Beecham Plc |
Process for the preparation of thiazolidinedione derivatives
|
HUP9902721A2
(hu)
|
1997-11-25 |
1999-12-28 |
The Procter & Gamble Co. |
Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
|
US20040058873A1
(en)
*
|
1998-03-12 |
2004-03-25 |
Esmond Robert W. |
Method for treating or preventing Alzheimer's disease
|
GB9824893D0
(en)
*
|
1998-11-12 |
1999-01-06 |
Smithkline Beckman Corp |
Novel method of treatment
|
WO2000028989A1
(en)
|
1998-11-12 |
2000-05-25 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
DZ2937A1
(fr)
|
1998-11-12 |
2004-03-15 |
Smithkline Beecham Plc |
Compositions nouvelles de sensibilidants à l'insuline.
|
WO2000030628A2
(en)
*
|
1998-11-20 |
2000-06-02 |
Genentech, Inc. |
Method of inhibiting angiogenesis
|
US6191154B1
(en)
|
1998-11-27 |
2001-02-20 |
Case Western Reserve University |
Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
|
US5968960A
(en)
*
|
1999-01-14 |
1999-10-19 |
The Regents Of The University Of California |
Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism
|
AU3073700A
(en)
*
|
1999-01-19 |
2000-08-07 |
Sankyo Company Limited |
Troglitazone-containing medicinal compositions for inhibiting apoptosis
|
US6204288B1
(en)
|
1999-03-08 |
2001-03-20 |
The University Of Mississippi |
1,2-dithiolane derivatives
|
US6127394A
(en)
*
|
1999-03-08 |
2000-10-03 |
The University Of Mississippi |
1,2-Dithiolane derivatives
|
WO2000059855A1
(en)
*
|
1999-04-01 |
2000-10-12 |
Esperion Therapeutics, Inc. |
Ether compounds, compositions, and uses thereof
|
US6214842B1
(en)
|
1999-05-12 |
2001-04-10 |
Michael S. Malamas |
Amino-thiazolidinediones useful in the treatment of insulin resistance and hyperglycemia
|
AU770870B2
(en)
*
|
1999-06-18 |
2004-03-04 |
Merck & Co., Inc. |
Arylthiazolidinedione and aryloxazolidinedione derivatives
|
JP2001072592A
(ja)
|
1999-07-01 |
2001-03-21 |
Kyowa Hakko Kogyo Co Ltd |
テロメラーゼ阻害剤
|
CN1321153A
(zh)
*
|
1999-07-01 |
2001-11-07 |
杰龙公司 |
端粒酶抑制剂及其使用方法
|
AR028299A1
(es)
|
1999-09-17 |
2003-05-07 |
Novartis Ag |
Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
|
US6559188B1
(en)
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
US6878749B2
(en)
*
|
1999-09-17 |
2005-04-12 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
US20040266834A1
(en)
*
|
1999-10-14 |
2004-12-30 |
Copland John A. |
Thiazolidinediones alone or in cabination with other therapeutic agents for cancer therapy
|
US20080108825A1
(en)
*
|
1999-11-08 |
2008-05-08 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
US7323496B2
(en)
*
|
1999-11-08 |
2008-01-29 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
US6723506B2
(en)
|
2000-01-20 |
2004-04-20 |
Brigham And Women's Hospital |
Method of identifying PAX8-PPAR gamma-nucleic acid molecules
|
DE122008000018I1
(de)
|
2000-01-21 |
2008-08-14 |
Novartis Pharma Ag |
Zusammensetzungen bestehend aus Dipeptidylpeptidase-IV Inhibitoren und Antidiabetica
|
US20080103302A1
(en)
*
|
2000-02-04 |
2008-05-01 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
US6680387B2
(en)
*
|
2000-04-24 |
2004-01-20 |
Aryx Therapeutics |
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
|
US6958355B2
(en)
*
|
2000-04-24 |
2005-10-25 |
Aryx Therapeutics, Inc. |
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
AU2001294673A1
(en)
*
|
2000-09-21 |
2002-04-02 |
Aryx Therapeutics |
Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
|
US20040122091A1
(en)
*
|
2000-10-11 |
2004-06-24 |
Esperion Therapeutics, Inc. |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
BR0114619A
(pt)
|
2000-10-11 |
2005-12-13 |
Esperion Therapeutics Inc |
Composto, composição farmacêutica, métodos para tratar ou prevenir uma doença cardiovascular, uma dislipidemia, uma dislipoproteinemia, um distúrbio do metabolismo da glicose, trombótico e associado com o receptor ativado do proliferador de peroxissoma, a doença de alzheimer, a sìndrome x ou sìndrome metabólica, a septicemia, a obesidade, pancreatite, a hipertensão, doença renal, câncer, a inflamação e a impotência, em um paciente e para reduzir o teor de gordura da carne em animal de criação e de colesterol de ovos de aves domésticas
|
WO2002030882A2
(en)
|
2000-10-11 |
2002-04-18 |
Esperion Therapeutics, Inc. |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
US7304093B2
(en)
*
|
2000-10-11 |
2007-12-04 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
EP1351916A2
(de)
|
2000-10-11 |
2003-10-15 |
Esperion Therapeutics Inc. |
Etherverbindungen und zusammensetzungen zu cholesterinkontrolle und verwandten verwendungen
|
CN1283610C
(zh)
|
2000-10-11 |
2006-11-08 |
埃斯佩里安医疗公司 |
用于控制胆固醇以及相关用途的酮化合物以及组合物
|
US6452014B1
(en)
|
2000-12-22 |
2002-09-17 |
Geron Corporation |
Telomerase inhibitors and methods of their use
|
EP1385549A2
(de)
*
|
2001-03-12 |
2004-02-04 |
Novartis AG |
Kombination aus nateglinid oder repaglinid mit mindestens einer weiteren antidiabetischen verbindung
|
US20060047000A1
(en)
*
|
2001-04-24 |
2006-03-02 |
Aryx Therapeutics, Inc. |
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
|
JP4152641B2
(ja)
*
|
2001-08-07 |
2008-09-17 |
クラシエ製薬株式会社 |
チアゾリジン誘導体の副作用軽減剤
|
US20040192771A1
(en)
*
|
2001-10-11 |
2004-09-30 |
Dasseux Jean-Louis Henri |
Ether compounds and compositions for cholesterol management and related uses
|
US20040204502A1
(en)
*
|
2001-10-11 |
2004-10-14 |
Dasseux Jean-Louis Henri |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
US20050020694A1
(en)
*
|
2001-10-11 |
2005-01-27 |
Dasseux Jean-Louis Henri |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
ITRM20020016A1
(it)
*
|
2002-01-15 |
2003-07-15 |
Sigma Tau Ind Farmaceuti |
Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
|
US20030236212A1
(en)
*
|
2002-04-10 |
2003-12-25 |
Jean-Louis Dasseux |
Functionalized long chain derivatives as acyl coenzyme-A mimics, compositions thereof, and methods of cholesterol management and related uses
|
US20050101565A1
(en)
*
|
2002-07-03 |
2005-05-12 |
Esperion Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating, preventing, and managing cholesterol, dyslipidemia, and related disorders
|
US8993773B2
(en)
|
2002-07-16 |
2015-03-31 |
Cadila Healthcare Limited |
Process to prepare pioglitazone via several novel intermediates
|
EP1521753B1
(de)
*
|
2002-07-16 |
2007-09-05 |
Cadila Healthcare Ltd. |
Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
|
US8216609B2
(en)
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
US8268352B2
(en)
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
US20040048910A1
(en)
*
|
2002-08-22 |
2004-03-11 |
Bove Susan Elizabeth |
Method of treating osteoarthritis
|
SI2404890T1
(sl)
|
2003-01-23 |
2017-12-29 |
Esperion Therapeutics Inc. |
Hidroksilne spojine in sestavki za uravnavanje holesterola in sorodne uporabe
|
EP1622898A1
(de)
*
|
2003-05-13 |
2006-02-08 |
Synthon B.V. |
Verfahren zur herstellung von thiazolidindion- derivaten und dazu gehörige verbindungen
|
US7230016B2
(en)
*
|
2003-05-13 |
2007-06-12 |
Synthon Ip Inc. |
Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
|
US20050107387A1
(en)
*
|
2003-05-13 |
2005-05-19 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders
|
NZ543741A
(en)
*
|
2003-05-30 |
2009-10-30 |
Ranbaxy Lab Ltd |
Substituted pyrrole derivatives and their use as HMG-Co inhibitors
|
WO2005002557A1
(en)
*
|
2003-07-03 |
2005-01-13 |
Warner-Lambert Company Llc |
Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
|
DE602004020649D1
(de)
*
|
2003-11-07 |
2009-05-28 |
Jj Pharma Inc |
Hdl-verstärkende kombinationstherapie-komplexe
|
US20050192347A1
(en)
*
|
2003-12-23 |
2005-09-01 |
Dasseux Jean-Louis H. |
Urea and thiourea compounds and compositions for cholesterol management and related uses
|
AU2003304703A1
(en)
|
2003-12-24 |
2005-08-03 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
WO2005080387A2
(en)
*
|
2004-02-20 |
2005-09-01 |
Synthon B.V. |
Processes for making pioglitazone and compounds of the processes
|
US7161756B2
(en)
*
|
2004-05-10 |
2007-01-09 |
Tandberg Data Storage Asa |
Method and system for communication between a tape drive and an external device
|
UY28951A1
(es)
*
|
2004-06-09 |
2006-01-31 |
Avanir Pharmaceuticals |
Pequenas moleculas para el tratamiento de hipercolesterolemia y enfermedades relacionadas
|
PE20050986A1
(es)
*
|
2004-06-09 |
2006-02-03 |
Avanir Pharmaceuticals |
Derivados heterociclicos mediadores del transporte inverso de colesterol
|
BRPI0511945A
(pt)
*
|
2004-06-09 |
2008-01-29 |
Avanir Pharmaceuticals |
mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
|
US20070269486A1
(en)
*
|
2005-03-14 |
2007-11-22 |
Conor Medsystems, Llc. |
Methods and Devices for Reducing Tissue Damage After Ischemic Injury
|
US8026377B2
(en)
*
|
2005-11-08 |
2011-09-27 |
Ranbaxy Laboratories, Limited |
Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
|
AR059838A1
(es)
*
|
2006-03-14 |
2008-04-30 |
Ranbaxy Lab Ltd |
Formulaciones para dosis estabilizantes de estatina
|
CA2646149A1
(en)
|
2006-03-16 |
2007-09-27 |
Metabolic Solutions Development Company |
Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
|
CN101454005B
(zh)
|
2006-03-16 |
2013-01-02 |
新陈代谢解决方案开发公司 |
用于治疗代谢性炎症介导的疾病的噻唑烷二酮类似物
|
WO2008010087A2
(en)
*
|
2006-07-14 |
2008-01-24 |
Ranbaxy Laboratories Limited |
Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
|
CL2008000684A1
(es)
|
2007-03-09 |
2008-08-01 |
Indigene Pharmaceuticals Inc |
Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de reductasa hmg-coa; formulacion de dosis unitaria; y uso en el tratamiento de una complicacion diabetica.
|
CN104163864B
(zh)
*
|
2007-03-30 |
2017-08-01 |
Ambrx公司 |
经修饰fgf‑21多肽和其用途
|
EP2431043A1
(de)
|
2007-05-23 |
2012-03-21 |
Amcol International Corporation |
Mit Cholesterin interagierende Phyllosilikate zur Unterdrückung der gastrointestinalen Cholesterinabsorption
|
ES2398313T3
(es)
*
|
2007-09-14 |
2013-03-15 |
Metabolic Solutions Development Company Llc |
5-(4-(2-(3-metoxifenil)-2-oxoetoxi)bencil)tiazolidin-2,4-diona para uso en el tratamiento de la diabetes
|
US8304441B2
(en)
|
2007-09-14 |
2012-11-06 |
Metabolic Solutions Development Company, Llc |
Thiazolidinedione analogues for the treatment of metabolic diseases
|
EP2383263B1
(de)
*
|
2008-12-30 |
2014-04-16 |
Industry-academic Cooperation Foundation, Chosun University |
Neues thiazolidindionderivat und dessen verwendung
|
MY163512A
(en)
|
2009-09-03 |
2017-09-15 |
Pfizer Vaccines Llc |
Pcsk9 vaccine
|
US9492422B2
(en)
|
2009-11-13 |
2016-11-15 |
Toray Industries, Inc. |
Therapeutic or prophylactic agent for diabetes
|
WO2011084453A1
(en)
|
2009-12-15 |
2011-07-14 |
Metabolic Solutions Development Company |
Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
|
JP2013520162A
(ja)
|
2010-01-22 |
2013-06-06 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
代謝障害の同定、査定、予防および治療のための組成物、キットおよび方法
|
MX2012012095A
(es)
*
|
2010-04-21 |
2012-12-17 |
Metabolic Solutions Dev Co Llc |
Analogos de tiazolidinadiona.
|
US20120094959A1
(en)
|
2010-10-19 |
2012-04-19 |
Bonnie Blazer-Yost |
Treatment of cystic diseases
|
US20140004142A1
(en)
|
2011-03-02 |
2014-01-02 |
Pfizer Inc. |
Pcsk9 vaccine
|
AU2013340478B2
(en)
|
2012-11-05 |
2018-08-23 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives (Cea) |
Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STAT5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse
|
WO2015109037A1
(en)
|
2014-01-15 |
2015-07-23 |
Deuterx, Llc |
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
|
WO2015123291A1
(en)
|
2014-02-11 |
2015-08-20 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Pcsk9 vaccine and methods of using the same
|
KR20240024362A
(ko)
|
2014-10-24 |
2024-02-23 |
브리스톨-마이어스 스큅 컴퍼니 |
변형된 fgf-21 폴리펩티드 및 그의 용도
|
WO2016071727A1
(en)
|
2014-11-04 |
2016-05-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the prevention and the treatment of rapidly progressive glomerulonephritis
|
CN114099496A
(zh)
|
2015-03-13 |
2022-03-01 |
艾斯柏伦治疗公司 |
含etc1002和依泽替米贝的组合及治疗方法
|
MA41793A
(fr)
|
2015-03-16 |
2018-01-23 |
Esperion Therapeutics Inc |
Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
|
EP3986859A1
(de)
|
2019-06-21 |
2022-04-27 |
Esperion Therapeutics, Inc. |
Verfahren zur herstellung von bempedosäure und zusammensetzungen davon
|